Stanley C. Erck

2020

In 2020, Stanley C. Erck earned a total compensation of $48.1M as President and CEO at Novavax, a 1,872% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$591,463
Option Awards$44,115,244
Salary$657,181
Stock Awards$2,710,730
Other$11,400
Total$48,086,018

Erck received $44.1M in option awards, accounting for 92% of the total pay in 2020.

Erck also received $591.5K in non-equity incentive plan, $657.2K in salary, $2.7M in stock awards and $11.4K in other compensation.

Rankings

In 2020, Stanley C. Erck's compensation ranked 33rd out of 8,688 executives tracked by ExecPay. In other words, Erck earned more than 99.6% of executives.

ClassificationRankingPercentile
All
33
out of 8,688
100th
Division
Manufacturing
5
out of 3,671
100th
Major group
Chemicals And Allied Products
3
out of 1,317
100th
Industry group
Drugs
3
out of 1,116
100th
Industry
Biological Products, Except Diagnostic Substances
1
out of 243
100th

Pay ratio

Stanley C. Erck's Pay$48,086,018
Median Employee's Pay$400,755
Pay Ratio

120

to 1

In 2020, the annual total compensation of Stanley C. Erck was $48,086,018.

The annual total compensation of the median employee at Novavax was $400,755.

The ratio of Stanley C. Erck's pay to the pay of median employee was therefore 120 to one.

Source: SEC filing on May 3, 2021.

Erck's colleagues

We found four more compensation records of executives who worked with Stanley C. Erck at Novavax in 2020.

2020

Gregory Glenn

Novavax

President, Research and Development

2020

John Trizzino

Novavax

Chief Financial Officer

2020

John Herrmann

Novavax

Chief Legal Officer

2020

Gregory Covino

Novavax

Chief Financial Officer

News

In-depth

You may also like